Immutep Ltd (ASX: IMM) is a biotechnology company that has been working in the field of developing immunotherapy treatments for cancer and autoimmune diseases; and the group is now focused on leveraging its technology and expertise in bringing new and innovative treatments and solutions to the market for patients. IMM aims to provide good shareholder value through the development of its flagship products.

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK